From: Role of chronic E. coli infection in the process of bladder cancer- an experimental study
Group | NF-κBp65 (ng/ml) | Bcl-2 (U/ml) | IL-6 (pg/ml) | |||||||
---|---|---|---|---|---|---|---|---|---|---|
3 months | 6 months | 9 months | 3 months | 6 months | 9 months | 3 months | 6 months | 9 months | ||
Group I | Range | 0.51- 0.67 | 0.51-0.75 | 0.60-0.87 | 293.30- 331.94 | 310.74-331.94 | 305.78- 348.24 | 12.65-15.20 | 13.55-16.95 | 14.5-17.00 |
Mean ± S.D | 0.57 ± 0.07 | 0.61 ± 0.08 | 0.70 ± 0.11 | 309.14 ± 14.55 | 320.61 ± 7.47 | 323.47 ± 14.33 | 14.09 ± 0.87 | 14.74 ± 1.23 | 15.63 ± 0.89 | |
Group II | Range | 0.52-1.13 | 0.91- 1.145 | 1.13-1.74 | 329.75-396.42 | 412.63-584.94 | 354.27- 681.57 | 17.77-22.44 | 20.91-25.11 | 24.76-29.69 |
Mean ± S.D | 0.92 ± 0.22a,d | 1.11 ± 0.19a,d | 1.30 ± 0.22a,c,d | 354.74 ± 23.44a,d | 485.36 ± 60.12a,c,d | 485.58 ± 120.36a | 19.76 ± 1.64a,d | 23.13 ± 1.46 a,d | 26.41 ± 1.89a,d | |
Group III | Range | 0.57- 1.05 | 1.02-1.50 | 1.39- 2.09 | 315.83-351.77 | 341.94-374.09 | 362.57-407.20 | 17.22-21.78 | 20.08-24.22 | 22.50-25.59 |
Mean ± S.D | 0.84 ± 0.17a,d | 1.27 ± 0.20a,d | 1.66 ± 0.27a,b | 331.78 ± 11.86 a,d | 361.59 ± 11.95a,b,d | 386.92 ± 19.14a,d | 19.21 ± 1.56a,d | 22.29 ± 1.48 a,d | 24.37 ± 1.32a,d | |
Group IV | Range | 0.94- 1.40 | 1.30-1.87 | 1.58-1.95 | 377.06-399.89 | 484.65-595.49 | 522.07- 726.57 | 22.00-27.46 | 26.61-34.78 | 35.87-43.51 |
Mean ± S.D | 1.19 ± 0.19a,b,c | 1.52 ± 0.21a,b,c | 1.72 ± 0.14a,b | 387.05 ± 8.40a,b,c | 544.54 ± 37.11a,b,c | 592.60 ± 75.22a,c | 24.80 ± 2.20a,b,c | 30.66 ± 3.20a,b,c | 40.55 ± 2.69a,b,c |